EMVISION MEDICAL DEVICES LTD - Announcements

Market Cap $176.8M Add to my watchlist

Healthcare Medical Devices

EMVision Medical Devices Limited is an Australia-based medical device company developing... EMVision Medical Devices Limited is an Australia-based medical device company developing an approach to looking inside the human body. The Company is engaged in the research and development of medical imaging and diagnostic technology (the EMVision Technology), for the purpose of commercializing a portable medical device for stroke diagnosis and monitoring as well as other medical imaging needs. The Company is developing and commercializing medical imaging diagnostics for various disease states and medical emergencies. The Company’s product pipeline includes portable, non-invasive, neuroimaging devices. Its lead product in development includes a portable, non-ionizing brain scanner, capable of producing images of biological tissue to provide insights for clinicians. Its second-generation device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location.More

Announcements

Filter Results

All Price Sensitive Only

EMV	Notification of cessation of securities - EMV		26/04/24	12.85KB	Share
EMV	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	24/04/24	281.83KB	Share
EMV	Stage 2 Insights Confirm Diagnostic & Clinical Viability	PRICE SENSITIVE	27/03/24	503.12KB	Share
EMV	ASA Milestone Achieved for $0.6m Grant Payment	PRICE SENSITIVE	13/03/24	181.09KB	Share
EMV	Initial Director's Interest Notice		07/03/24	183.58KB	Share
EMV	Final Director's Interest Notice		07/03/24	243.33KB	Share
EMV	Board Changes		07/03/24	186.87KB	Share
EMV	Becoming a substantial holder		01/03/24	5.01MB	Share
EMV	Cleansing Notice		01/03/24	165.66KB	Share
EMV	Notification of cessation of securities - EMV		01/03/24	12.88KB	Share
EMV	Application for quotation of securities - EMV		01/03/24	18.54KB	Share
EMV	Application for quotation of securities - EMV		01/03/24	15.63KB	Share
EMV	CEO Half Yearly Update		29/02/24	276.79KB	Share
EMV	Half Yearly Report and Accounts	PRICE SENSITIVE	29/02/24	577.51KB	Share
EMV	Proposed issue of securities - EMV		29/02/24	14.77KB	Share
EMV	Strategic A$15.28M Investment from Keysight Technologies	PRICE SENSITIVE	29/02/24	241.94KB	Share
EMV	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	279.2KB	Share
EMV	EMVision Receives $2.58m R&D Rebate & ASA Milestone Achieved	PRICE SENSITIVE	18/12/23	206.03KB	Share
EMV	Notification of cessation of securities - EMV		12/12/23	21.71KB	Share
EMV	Stage 2 Trial Recruitment Tartget Reached & EMU Unveiled	PRICE SENSITIVE	27/11/23	626.35KB	Share
EMV	Amended Constitution		21/11/23	555.23KB	Share
EMV	Results of Annual General Meeting		15/11/23	176.65KB	Share
EMV	AGM CEO Presentation including Latest Imaging Case Studies	PRICE SENSITIVE	15/11/23	925.63KB	Share
EMV	AGM Chairman's Address	PRICE SENSITIVE	15/11/23	185.54KB	Share
EMV	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/23	279.77KB	Share
EMV	Notification regarding unquoted securities - EMV		26/10/23	26.5KB	Share
EMV	Gen 2 Advanced Prototype Assembled	PRICE SENSITIVE	24/10/23	368.06KB	Share
EMV	Notice of Annual General Meeting/Proxy Form		13/10/23	745.92KB	Share
EMV	Encouraging Interim Clinical Trial Results	PRICE SENSITIVE	10/10/23	301.22KB	Share
EMV	Change of Director's Interest Notice		29/09/23	260.27KB	Share
EMV	Notification of cessation of securities - EMV		29/09/23	21.71KB	Share
EMV	Date of AGM & Closing Date For Director Nominations		20/09/23	121.22KB	Share
EMV	ASX Small & Mid Cap Conference Investor Presentation		20/09/23	2.13MB	Share
EMV	Cleansing Notice		18/09/23	122.82KB	Share
EMV	Application for quotation of securities - EMV		18/09/23	25.34KB	Share
EMV	Notification regarding unquoted securities - EMV		18/09/23	27.63KB	Share
EMV	Employee Incentive Plan Issue		18/09/23	166.67KB	Share
EMV	Notification of cessation of securities - EMV		11/09/23	21.7KB	Share
EMV	Appendix 4G & Corporate Governance Statement		30/08/23	488.68KB	Share
EMV	Appendix 4E & Annual Report to 30 June 2023	PRICE SENSITIVE	30/08/23	2.65MB	Share
EMV	Latest Imaging and Clinical Trial Insights	PRICE SENSITIVE	22/08/23	439.6KB	Share
EMV	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/23	278.88KB	Share
EMV	Clinical Trial Progress & ASA Milestone Achieved	PRICE SENSITIVE	27/07/23	296.23KB	Share
EMV	Recruitment at Royal Melbourne Hospital Commences	PRICE SENSITIVE	29/06/23	163.91KB	Share
EMV	$1.75M Manufacturing Grant Payment Received	PRICE SENSITIVE	13/06/23	166.25KB	Share
EMV	Leadership Transition	PRICE SENSITIVE	31/05/23	174.93KB	Share
EMV	Stage 2 of Clinical Trial Activated	PRICE SENSITIVE	29/05/23	305.1KB	Share
EMV	Change of Director's Interest Notice		05/05/23	250.67KB	Share
EMV	Cleansing Notice		05/05/23	122.22KB	Share
EMV	Application for quotation of securities - EMV		05/05/23	26.4KB	Share
EMV	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/04/23	280KB	Share
EMV	Notification regarding unquoted securities - EMV		24/04/23	34.85KB	Share
EMV	Product Development Milestones & Grant Funding Achieved	PRICE SENSITIVE	17/04/23	332.81KB	Share
EMV	Cleansing Notice		03/04/23	164KB	Share
EMV	Application for quotation of securities - EMV		03/04/23	25.16KB	Share
EMV	Clinical Advisory Board Appointment		14/03/23	195.4KB	Share
EMV	CEO Half-Year Update	PRICE SENSITIVE	28/02/23	191.51KB	Share
EMV	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/23	602.84KB	Share
EMV	Clinical Trial Stage 1 Enrolment Completed	PRICE SENSITIVE	21/02/23	295.79KB	Share
EMV	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/23	284.35KB	Share
EMV	Trial Progressing on Target and ASA Milestone Achieved	PRICE SENSITIVE	25/01/23	197.84KB	Share
EMV	Change of Director's Interest Notice X 6		01/12/22	391.74KB	Share
EMV	Notification regarding unquoted securities - EMV		01/12/22	33.04KB	Share
EMV	$8.8m In Non-Dilutive Funding To Be Received This Quarter	PRICE SENSITIVE	01/12/22	218.02KB	Share
EMV	EMVision Commences Clinical Trial	PRICE SENSITIVE	30/11/22	192.9KB	Share
EMV	Results of Annual General Meeting		16/11/22	138.68KB	Share
EMV	AGM Chairman Address and Presentation	PRICE SENSITIVE	16/11/22	963.15KB	Share
EMV	Portable Brain Scanner Delivered to First Clinical Site	PRICE SENSITIVE	14/11/22	195.25KB	Share
EMV	EMVision Backed By NSW Medical Devices Fund With $2.5m Grant	PRICE SENSITIVE	11/11/22	207.48KB	Share
EMV	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/22	307.4KB	Share
EMV	$5m Modern Manufacturing Initiative Funding Agreement Signed	PRICE SENSITIVE	25/10/22	310.3KB	Share
EMV	Notice of Annual General Meeting/Proxy Form		14/10/22	1.07MB	Share
EMV	Ethics Approval Received For Multi-Centre Clinical Trial	PRICE SENSITIVE	04/10/22	315.51KB	Share
EMV	Cleansing Notice		16/09/22	122.74KB	Share
EMV	Application for quotation of securities - EMV		16/09/22	25.25KB	Share
EMV	Notification regarding unquoted securities - EMV		16/09/22	25.9KB	Share
EMV	Employee Incentive Plan Issue	PRICE SENSITIVE	16/09/22	166.55KB	Share
EMV	Date of AGM and Closing Date for Director Nominations		16/09/22	176.37KB	Share
EMV	Investor Presentation - E&P Healthcare Conference		06/09/22	3.39MB	Share
EMV	Appendix 4G & Corporate Governance Statement		30/08/22	513.41KB	Share
EMV	Appendix 4E & Annual Report to 30 June 2022	PRICE SENSITIVE	30/08/22	2.09MB	Share
EMV	$5m Modern Manufacturing Initiative Grant Proceeding	PRICE SENSITIVE	29/08/22	137.66KB	Share
EMV	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/22	323.36KB	Share
EMV	Centres of Excellence Confirmed as First Two Clinical Sites	PRICE SENSITIVE	12/07/22	181.61KB	Share
EMV	Cleansing Notice		29/06/22	122.77KB	Share
EMV	Application for quotation of securities - EMV		29/06/22	24.95KB	Share
EMV	EMVision Achieves First Responder Milestone	PRICE SENSITIVE	27/06/22	304.92KB	Share
EMV	EMVision Awarded $5m Non-Dilutive Funding via MMI Grant	PRICE SENSITIVE	18/05/22	184.73KB	Share
EMV	Trading Halt	PRICE SENSITIVE	16/05/22	261.38KB	Share
EMV	Pause in Trading	PRICE SENSITIVE	16/05/22	117.04KB	Share
EMV	Cleansing Notice		13/05/22	122.34KB	Share
EMV	Application for quotation of securities - EMV		13/05/22	24.94KB	Share
EMV	EMVision Secures Strategic Agreement With Keysight	PRICE SENSITIVE	04/05/22	270.57KB	Share
EMV	Trading Halt	PRICE SENSITIVE	02/05/22	585.36KB	Share
EMV	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/22	276.94KB	Share
EMV	New Appointments to Clinical Advisory Board	PRICE SENSITIVE	09/03/22	185.38KB	Share
EMV	S&P DJI Announces March 2022 Quarterly Rebalance	PRICE SENSITIVE	04/03/22	175.5KB	Share
EMV	CEO Half-Year Update	PRICE SENSITIVE	24/02/22	208.31KB	Share
EMV	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/22	782.1KB	Share
EMV	International Stroke Conference New Orleans Presentation		14/02/22	1.56MB	Share

EMV Notification of cessation of securities - EMV
26/04/24		12.85KB	Share
EMV Quarterly Activities/Appendix 4C Cash Flow Report
24/04/24	PRICE SENSITIVE	281.83KB	Share
EMV Stage 2 Insights Confirm Diagnostic & Clinical Viability
27/03/24	PRICE SENSITIVE	503.12KB	Share
EMV ASA Milestone Achieved for $0.6m Grant Payment
13/03/24	PRICE SENSITIVE	181.09KB	Share
EMV Initial Director's Interest Notice
07/03/24		183.58KB	Share
EMV Final Director's Interest Notice
07/03/24		243.33KB	Share
EMV Board Changes
07/03/24		186.87KB	Share
EMV Becoming a substantial holder
01/03/24		5.01MB	Share
EMV Cleansing Notice
01/03/24		165.66KB	Share
EMV Notification of cessation of securities - EMV
01/03/24		12.88KB	Share
EMV Application for quotation of securities - EMV
01/03/24		18.54KB	Share
EMV Application for quotation of securities - EMV
01/03/24		15.63KB	Share
EMV CEO Half Yearly Update
29/02/24		276.79KB	Share
EMV Half Yearly Report and Accounts
29/02/24	PRICE SENSITIVE	577.51KB	Share
EMV Proposed issue of securities - EMV
29/02/24		14.77KB	Share
EMV Strategic A$15.28M Investment from Keysight Technologies
29/02/24	PRICE SENSITIVE	241.94KB	Share
EMV Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	279.2KB	Share
EMV EMVision Receives $2.58m R&D Rebate & ASA Milestone Achieved
18/12/23	PRICE SENSITIVE	206.03KB	Share
EMV Notification of cessation of securities - EMV
12/12/23		21.71KB	Share
EMV Stage 2 Trial Recruitment Tartget Reached & EMU Unveiled
27/11/23	PRICE SENSITIVE	626.35KB	Share
EMV Amended Constitution
21/11/23		555.23KB	Share
EMV Results of Annual General Meeting
15/11/23		176.65KB	Share
EMV AGM CEO Presentation including Latest Imaging Case Studies
15/11/23	PRICE SENSITIVE	925.63KB	Share
EMV AGM Chairman's Address
15/11/23	PRICE SENSITIVE	185.54KB	Share
EMV Quarterly Activities/Appendix 4C Cash Flow Report
31/10/23	PRICE SENSITIVE	279.77KB	Share
EMV Notification regarding unquoted securities - EMV
26/10/23		26.5KB	Share
EMV Gen 2 Advanced Prototype Assembled
24/10/23	PRICE SENSITIVE	368.06KB	Share
EMV Notice of Annual General Meeting/Proxy Form
13/10/23		745.92KB	Share
EMV Encouraging Interim Clinical Trial Results
10/10/23	PRICE SENSITIVE	301.22KB	Share
EMV Change of Director's Interest Notice
29/09/23		260.27KB	Share
EMV Notification of cessation of securities - EMV
29/09/23		21.71KB	Share
EMV Date of AGM & Closing Date For Director Nominations
20/09/23		121.22KB	Share
EMV ASX Small & Mid Cap Conference Investor Presentation
20/09/23		2.13MB	Share
EMV Cleansing Notice
18/09/23		122.82KB	Share
EMV Application for quotation of securities - EMV
18/09/23		25.34KB	Share
EMV Notification regarding unquoted securities - EMV
18/09/23		27.63KB	Share
EMV Employee Incentive Plan Issue
18/09/23		166.67KB	Share
EMV Notification of cessation of securities - EMV
11/09/23		21.7KB	Share
EMV Appendix 4G & Corporate Governance Statement
30/08/23		488.68KB	Share
EMV Appendix 4E & Annual Report to 30 June 2023
30/08/23	PRICE SENSITIVE	2.65MB	Share
EMV Latest Imaging and Clinical Trial Insights
22/08/23	PRICE SENSITIVE	439.6KB	Share
EMV Quarterly Activities/Appendix 4C Cash Flow Report
28/07/23	PRICE SENSITIVE	278.88KB	Share
EMV Clinical Trial Progress & ASA Milestone Achieved
27/07/23	PRICE SENSITIVE	296.23KB	Share
EMV Recruitment at Royal Melbourne Hospital Commences
29/06/23	PRICE SENSITIVE	163.91KB	Share
EMV $1.75M Manufacturing Grant Payment Received
13/06/23	PRICE SENSITIVE	166.25KB	Share
EMV Leadership Transition
31/05/23	PRICE SENSITIVE	174.93KB	Share
EMV Stage 2 of Clinical Trial Activated
29/05/23	PRICE SENSITIVE	305.1KB	Share
EMV Change of Director's Interest Notice
05/05/23		250.67KB	Share
EMV Cleansing Notice
05/05/23		122.22KB	Share
EMV Application for quotation of securities - EMV
05/05/23		26.4KB	Share
EMV Quarterly Activities/Appendix 4C Cash Flow Report
27/04/23	PRICE SENSITIVE	280KB	Share
EMV Notification regarding unquoted securities - EMV
24/04/23		34.85KB	Share
EMV Product Development Milestones & Grant Funding Achieved
17/04/23	PRICE SENSITIVE	332.81KB	Share
EMV Cleansing Notice
03/04/23		164KB	Share
EMV Application for quotation of securities - EMV
03/04/23		25.16KB	Share
EMV Clinical Advisory Board Appointment
14/03/23		195.4KB	Share
EMV CEO Half-Year Update
28/02/23	PRICE SENSITIVE	191.51KB	Share
EMV Half Yearly Report and Accounts
28/02/23	PRICE SENSITIVE	602.84KB	Share
EMV Clinical Trial Stage 1 Enrolment Completed
21/02/23	PRICE SENSITIVE	295.79KB	Share
EMV Quarterly Activities/Appendix 4C Cash Flow Report
31/01/23	PRICE SENSITIVE	284.35KB	Share
EMV Trial Progressing on Target and ASA Milestone Achieved
25/01/23	PRICE SENSITIVE	197.84KB	Share
EMV Change of Director's Interest Notice X 6
01/12/22		391.74KB	Share
EMV Notification regarding unquoted securities - EMV
01/12/22		33.04KB	Share
EMV $8.8m In Non-Dilutive Funding To Be Received This Quarter
01/12/22	PRICE SENSITIVE	218.02KB	Share
EMV EMVision Commences Clinical Trial
30/11/22	PRICE SENSITIVE	192.9KB	Share
EMV Results of Annual General Meeting
16/11/22		138.68KB	Share
EMV AGM Chairman Address and Presentation
16/11/22	PRICE SENSITIVE	963.15KB	Share
EMV Portable Brain Scanner Delivered to First Clinical Site
14/11/22	PRICE SENSITIVE	195.25KB	Share
EMV EMVision Backed By NSW Medical Devices Fund With $2.5m Grant
11/11/22	PRICE SENSITIVE	207.48KB	Share
EMV Quarterly Activities/Appendix 4C Cash Flow Report
31/10/22	PRICE SENSITIVE	307.4KB	Share
EMV $5m Modern Manufacturing Initiative Funding Agreement Signed
25/10/22	PRICE SENSITIVE	310.3KB	Share
EMV Notice of Annual General Meeting/Proxy Form
14/10/22		1.07MB	Share
EMV Ethics Approval Received For Multi-Centre Clinical Trial
04/10/22	PRICE SENSITIVE	315.51KB	Share
EMV Cleansing Notice
16/09/22		122.74KB	Share
EMV Application for quotation of securities - EMV
16/09/22		25.25KB	Share
EMV Notification regarding unquoted securities - EMV
16/09/22		25.9KB	Share
EMV Employee Incentive Plan Issue
16/09/22	PRICE SENSITIVE	166.55KB	Share
EMV Date of AGM and Closing Date for Director Nominations
16/09/22		176.37KB	Share
EMV Investor Presentation - E&P Healthcare Conference
06/09/22		3.39MB	Share
EMV Appendix 4G & Corporate Governance Statement
30/08/22		513.41KB	Share
EMV Appendix 4E & Annual Report to 30 June 2022
30/08/22	PRICE SENSITIVE	2.09MB	Share
EMV $5m Modern Manufacturing Initiative Grant Proceeding
29/08/22	PRICE SENSITIVE	137.66KB	Share
EMV Quarterly Activities/Appendix 4C Cash Flow Report
28/07/22	PRICE SENSITIVE	323.36KB	Share
EMV Centres of Excellence Confirmed as First Two Clinical Sites
12/07/22	PRICE SENSITIVE	181.61KB	Share
EMV Cleansing Notice
29/06/22		122.77KB	Share
EMV Application for quotation of securities - EMV
29/06/22		24.95KB	Share
EMV EMVision Achieves First Responder Milestone
27/06/22	PRICE SENSITIVE	304.92KB	Share
EMV EMVision Awarded $5m Non-Dilutive Funding via MMI Grant
18/05/22	PRICE SENSITIVE	184.73KB	Share
EMV Trading Halt
16/05/22	PRICE SENSITIVE	261.38KB	Share
EMV Pause in Trading
16/05/22	PRICE SENSITIVE	117.04KB	Share
EMV Cleansing Notice
13/05/22		122.34KB	Share
EMV Application for quotation of securities - EMV
13/05/22		24.94KB	Share
EMV EMVision Secures Strategic Agreement With Keysight
04/05/22	PRICE SENSITIVE	270.57KB	Share
EMV Trading Halt
02/05/22	PRICE SENSITIVE	585.36KB	Share
EMV Quarterly Activities/Appendix 4C Cash Flow Report
29/04/22	PRICE SENSITIVE	276.94KB	Share
EMV New Appointments to Clinical Advisory Board
09/03/22	PRICE SENSITIVE	185.38KB	Share
EMV S&P DJI Announces March 2022 Quarterly Rebalance
04/03/22	PRICE SENSITIVE	175.5KB	Share
EMV CEO Half-Year Update
24/02/22	PRICE SENSITIVE	208.31KB	Share
EMV Half Yearly Report and Accounts
24/02/22	PRICE SENSITIVE	782.1KB	Share
EMV International Stroke Conference New Orleans Presentation
14/02/22		1.56MB	Share

REFRESH

1 2

(20min delay)
Last $2.07		Change 0.000(0.00%)		Mkt cap ! $176.8M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	304	$2.01

Sellers (Offers)

Price($)	Vol.	No.
$2.06	5466	3

View Market Depth

No.	Vol.	Price($)
2	304	2.010
1	4800	2.000
1	2323	1.980
1	1063	1.975
1	1068	1.965

Price($)	Vol.	No.
2.060	5466	3
2.070	17547	2
2.100	1500	1
2.150	627	1
2.160	803	1

Last trade - 10.02am 09/05/2024 (20 minute delay)


Last $2.06		Change 0.000 ( 0.16 %)
Open	High	Low	Volume
$2.06	$2.06	$2.06	1000
Last updated 10.35am 09/05/2024 ?

EMV (ASX) Chart

Day chart unavailable

EMVISION MEDICAL DEVICES LTD - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories